February 05, 2021
New Israeli Drug Cured 29 Of 30 Moderate/Serious COVID Cases In Days — Hospital-Times Of Israel
A new coronavirus treatment being developed at Tel Aviv’s Ichilov Medical Center has successfully completed phase 1 trials and appears to have helped numerous moderate-to-serious cases of COVID-19 quickly recover from the disease, the hospital said Friday. Hailing a “huge breakthrough,” the hospital said Prof. Nadir Arber’s EXO-CD24 substance had been administered to 30 patients whose conditions were moderate or worse, and all 30 recovered — 29 of them within three to five days. Times Of Israel, 02/05/2021
Next Article Previous Article